Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Hsu, Mei‐Hwei Chang, Y. Ni, Cheng‐Lun Chiang, Huey‐Ling Chen, Jia‐Feng Wu, Pei‐Jer Chen (2010)
No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization.The Journal of infectious diseases, 201 8
Y. Kamatani, S. Wattanapokayakit, H. Ochi, T. Kawaguchi, A. Takahashi, N. Hosono, M. Kubo, T. Tsunoda, N. Kamatani, H. Kumada, Aekkachai Puseenam, T. Sura, Y. Daigo, K. Chayama, W. Chantratita, Yusuke Nakamura, K. Matsuda (2009)
A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in AsiansNature Genetics, 41
D. Candotti, J. Allain (2009)
Transfusion-transmitted hepatitis B virus infection.Journal of hepatology, 51 4
Xiaofeng Liang, Shengli Bi, Weizhong Yang, Longde Wang, Gang Cui, F. Cui, Yong Zhang, Jianhua Liu, X. Gong, Yuan-sheng Chen, Fu-zhen Wang, Hui-hui Zheng, Feng Wang, Jing Guo, Z. Jia, Jing-chen Ma, Huaqing Wang, Huiming Luo, Li Li, Shuigao Jin, S. Hadler, Yu Wang (2009)
Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.Vaccine, 27 47
Y. Komiya, K. Katayama, H. Yugi, M. Mizui, H. Matsukura, T. Tomoguri, Y. Miyakawa, A. Tabuchi, J. Tanaka, H. Yoshizawa (2007)
Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype CTransfusion, 48
R. Biswas, E. Tabor, C. Hsia, D. Wright, M. Laycock, E. Fiebig, L. Peddada, Richard Smith, G. Schreiber, J. Epstein, G. Nemo, M. Busch (2003)
Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infectionTransfusion, 43
D. Lavanchy (2012)
Viral hepatitis: global goals for vaccination.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 55 4
C. Thio, David Thomas, P. Karacki, Xiaojiang Gao, D. Marti, R. Kaslow, J. Goedert, M. Hilgartner, S. Strathdee, P. Duggal, S. O’Brien, J. Astemborski, M. Carrington (2003)
Comprehensive Analysis of Class I and Class II HLA Antigens and Chronic Hepatitis B Virus InfectionJournal of Virology, 77
(2012)
Principles of Hepatitis B and Hepatitis B in Clinic, 4th ed., People’s Health
S. Kleinman, N. Lelie, M. Busch (2009)
Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusionTransfusion, 49
J. Allain (2004)
Occult hepatitis B virus infection: implications in transfusionVox Sanguinis, 86
(2011)
Analysis of the relationship between hepatitis B virus infection and hematologic malignancies
Ya-Fang Wu, Li‐Yu Wang, Tsung‐Dao Lee, H. Lin, Chi-Tan Hu, Mu-Liang Cheng, S. Lo (2004)
HLA phenotypes and outcomes of hepatitis B virus infection in TaiwanJournal of Medical Virology, 72
C. Hsia, R. Purcell, M. Farshid, P. Lachenbruch, M. Yu (2006)
Quantification of hepatitis B virus genomes and infectivity in human serum samplesTransfusion, 46
田原 文子 (2011)
Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection : transmission experiments to chimeric mice with human liver repopulated hepatocytes
G. Calderón, F. González‐Velázquez, C. González-Bonilla, Bárbara Novelo-Garza, José-Juan Terrazas, M. Martínez-Rodríguez, Silvia Cortés‐Márquez, Juan Blanco‐Flores, A. Rodríguez-Rodríguez, Maria Campo, R. Cortés-Gómez, M. Mejía‐Bocanegra (2009)
Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in MexicoTransfusion, 49
Mei‐Hwei Chang, Chien-Jen Chen, M. Lai, H. Hsu, Tzee-Chung Wu, M. Kong, Der-Cherng Liang, W. Shau, Ding‐Shinn Chen (1997)
Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.The New England journal of medicine, 336 26
(2009)
Blood screening progress of hepatitis B virus
(2009)
A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis
(2009)
Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients
Ching‐lung Lai, V. Ratziu, M. Yuen, T. Poynard (2003)
Viral hepatitis BThe Lancet, 362
A. Zanetti, P. Damme, D. Shouval (2008)
The global impact of vaccination against hepatitis B: a historical overview.Vaccine, 26 49
(2012)
Blood screening progress of hepatitis B virus, Chin
A. Servant‐Delmas, M. Mercier, Marie-Hélène Ghouzzi, A. Girault, F. Bouchardeau, J. Pillonel, S. Laperche (2010)
National survey of hepatitis B virus (HBV) polymorphism in asymptomatic HBV blood donors from 1999 to 2007 in FranceTransfusion, 50
S. Jammeh, F. Tavner, R. Watson, H. Thomas, P. Karayiannis (2008)
Effect of basal core promoter and pre-core mutations on hepatitis B virus replication.The Journal of general virology, 89 Pt 4
W. Roth, M. Busch, A. Schuller, S. Ismay, A. Cheng, C. Seed, C. Jungbauer, P. Minsk, D. Sondag‐Thull, S. Wendel, J. Levi, M. Fearon, G. Delage, Y. Xie, I. Jukić, P. Turek, H. Ullum, V. Tefanova, M. Tilk, R. Reimal, J. Castrén, M. Naukkarinen, A. Assal, C. Jork, M. Hourfar, P. Michel, R. Offergeld, L. Pichl, Michael Schmidt, V. Schottstedt, E. Seifried, F. Wagner, Marijke Weber‐Schehl, C. Politis, C. Lin, W. Tsoi, J. O’Riordan, A. Gottreich, E. Shinar, V. Yahalom, C. Velati, M. Satake, N. Sanad, I. Sisene, A. Bon, M. Koppelmann, P. Flanagan, O. Flesland, E. Brojer, M. Łętowska, F. Nascimento, E. Zhiburt, S. Chua, D. Teo, S. Stezinar, M. Vermeulen, R. Reddy, Q. Park, E. Castro, A. Eiras, I. Fraile, P. Torres, B. Ekermo, C. Niederhauser, H. Chen, S. Oota, L. Brant, R. Eglin, L. Jarvis, L. Mohabir, J. Brodsky, G. Foster, C. Jennings, E. Notari, S. Stramer, D. Kessler, C. Hillyer, H. Kamel, L. Katz, C. Taylor, S. Panzer, H. Reesink (2012)
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009Vox Sanguinis, 102
AbstractAs one of the main factors affecting safe blood transfusion, hepatitis B virus (HBV) infection through blood transfer seriously endangers human health. Therefore, studies should focus on both reducing infection rate of HBV and accurately evaluating the risk of infection. This study discusses the main factors affecting HBV infection that results from blood transfusions, with the aim of gaining insights into reducing HBV infection.
Infection International – de Gruyter
Published: Nov 28, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.